1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Bangkok Dusit Medical Services Public Company Limited

Bangkok Dusit Medical Services Public Company Limited

BDMS-R.BK
Bangkok Dusit Medical Services Public Company LimitedTH flagStock Exchange of Thailand
19.70
THB
- -
- -
313.07BMarket Cap
Bangkok Dusit Medical Services Public Company Limited
BDMS-R.BK
(Stock Exchange of Thailand)

Recent

price

19.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.95
2.48
2.94
3.27
3.62
4.06
4.38
4.64
4.97
5.25
4.28
4.68
5.78
6.35
6.79
7.02
7.02
Revenue per Share
0.19
0.3
0.51
0.4
0.48
0.52
0.54
0.66
0.59
0.99
0.45
0.5
0.79
0.9
1.01
1
0.98
Basic EPS, GAAP
0.26
0.17
0.16
0.04
0.15
0.42
0.22
-0.3
0.46
0.42
0.32
0.64
0.96
0.79
0.71
0.76
0.76
Free Cash Flow per Basic Share
0.07
0.07
0.11
0.18
0.2
0.23
0.36
0.32
0.36
0.44
0.3
0.8
0.5
0.65
0.7
0.75
0.35
Dividend per Share
0.54
0.73
1.08
1.31
1.51
1.79
1.98
2.32
2.52
3
3.06
2.79
3.12
3.37
3.64
3.88
4.13
Book Value per Share
1.17
1.45
1.72
1.97
1.95
2.35
2.55
3
3.45
4.27
4.57
4.34
4.71
5.02
5.29
5.64
5.91
Tangible Book Value per Share
12,188
14,619
15,455
15,463
15,491
15,491
15,491
15,491
15,570
15,743
15,892
15,892
15,892
15,892
15,892
15,892
15,892
Basic Weighted Avg Shares
23,734
36,234
45,478
50,615
56,054
62,834
67,904
71,933
77,373
82,723
68,074
74,451
91,934
100,853
107,867
111,507
111,602
Sales/Revenue/Turnover
14.27
16.08
17.12
15.08
15.99
15.65
14.61
14.33
15.24
14.57
12.52
15.07
18.47
18.73
18.96
18.08
17.71
Operating Margin (%)
2,123
2,707
2,951
3,244
3,716
4,387
4,803
5,168
5,386
5,752
6,413
6,321
5,950
5,848
6,132
6,848
7,026
Depreciation Expense
2,295
4,386
7,849
6,261
7,394
8,021
8,386
10,216
9,191
15,517
7,214
7,936
12,606
14,358
15,987
15,848
15,560
Net Income, GAAP
24.67
23.94
16.48
17.59
17.89
18.53
17.98
19.51
22.12
19.48
26.45
19.85
19.58
20.22
18.65
18.41
18.39
Effective Tax Rate (%)
9.67
12.1
17.26
12.37
13.19
12.76
12.35
14.2
11.88
18.76
10.6
10.66
13.71
14.24
14.82
14.21
13.94
Profit Margin (%)
-1,458
1,298
-2,287
-1,513
-1,160
-1,712
-5,282
977
-13,301
-2,938
18,792
8,539
7,183
5,112
1,646
-520
3,435
Working Capital
7,279
15,598
15,708
18,789
27,411
27,060
25,933
37,711
24,753
19,130
23,736
15,384
17,182
15,317
13,540
10,608
10,676
LT Debt
16,283
32,892
38,387
42,685
47,717
54,997
58,305
65,871
73,438
87,182
91,463
87,765
93,949
99,091
103,927
110,009
114,301
Total Equity
9.34
11.39
11.93
10.13
10.13
9.72
9.26
8.47
8.38
8.6
5.48
8.03
12.11
12.73
13.78
13.07
12.6
Return on Invested Capital (%)
14.39
20.2
24.59
16.31
15.47
14.7
13.92
15.5
12.03
20.04
9.79
11.09
17.3
18.73
20.3
19.13
18.49
Return on Capital (%)
36.45
50.92
57.31
33.9
33.94
31.41
28.74
30.73
24.48
35.87
15.03
17.06
26.84
27.83
28.68
26.53
24.33
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
8,131
6,879
3,345
LT Borrowings
3,000
3,000
3,000
LT Finance Leases
7,530
7,608
7,676
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15,892
15,892
15,892
Market Capitalization
325,786
306,716
298,770

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
22,132
23,109
25,273
Cash, Cash Equivalents & STI
7,050
7,242
8,122
Accounts Receivable, Net
11,119
11,638
12,313
Inventories
3,042
3,422
3,150
Total Current Liabilities
25,633
23,629
21,838
Payables & Accruals
15,955
15,236
17,325
ST Debt
8,131
6,879
3,345
Deferred Revenue
204
190
193

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.33%
3.84%
5.85%
Free Cash Flow
-43.39%
26.13%
6.62%
Net Income, GAAP
12.49%
18.65%
-0.87%
Sales/Revenue/Turnover
6.36%
10.58%
3.37%
Total Cash Common Dividend
22.66%
35.18%
7.17%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
26,609
25,704
28,151
27,404
107,867
2025
28,084
26,727
28,243
28,453
111,507
2026
28,179
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
0.21
0.27
- -
1.01
2025
0.27
0.22
0.27
- -
1
2026
0.26
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.35
0.35
- -
0.7
2025
- -
- -
0.35
- -
0.75
2026
- -
- -
- -
- -
- -
Similar Companies
COMPASS Pathways plc (CMPS)
Brookdale Senior Living Inc. 7. (BKDT)
Clariane SE (CLARI.PA)
Stem Cell Authority, Ltd. (SCAL)
Jupiter Life Line Hospitals Limited (JLHL.BO)
Dr. Lalchandani Labs Ltd. (DLCL.BO)
Business
Bangkok Dusit Medical Services Public Company Limited (BDMS) is Thailand's largest private healthcare provider, operating a comprehensive network of approximately 47 hospitals under six main hospital groups: Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital, Paolo Memorial Hospital, and the Royal Bangkok Hospital. The company offers a wide range of medical services including general and specialized hospital care; medical laboratories; pharmaceutical production and distribution; saline production; pharmacies; asset management for healthcare business; accounting, technology, and information services; wellness clinics and resorts; emergency medical transportation through BDMS Medevac Center; and health insurance brokerage. BDMS serves both domestic and international patients with advanced medical technologies and staffed by over 11,000 doctors and 8,000 nurses, delivering treatments across diverse fields such as orthopedics, cancer, pediatrics, and heart surgery. Founded in 1969 and headquartered in Bangkok, Thailand, BDMS has expanded its footprint with hospital operations in Thailand and Cambodia. Recent significant developments include the investment of THB10-11 billion annually through 2027 for facility maintenance, new project developments, and hospital network expansion, notably the THB23.5 billion BDMS Silver Wellness and Residence Project. Additionally, BDMS has entered strategic partnerships such as with Prudential to provide cost-certain breast cancer treatments for insured customers across several Asian countries and is expanding bed capacity steadily from approximately 8,800 beds in 2024 to about 9,600 beds by 2027-2029, including new hospital openings and specialized centers like the Bangkok Proton Center. These initiatives reflect BDMS's commitment to enhancing healthcare quality and accessibility, positioning it as a leading tertiary healthcare provider in the Asia-Pacific region.